Expanding our understanding of lower urinary tract symptoms and incontinence in adults with pompe disease

JIMD Reports

Volumn 20, Issue , 2015, Pages 5-10

  McNamara, Erin R ^a   Austin, Stephanie ^b   Case, Laura ^b   Wiener, John S ^b   Peterson, Andrew C ^b   Kishnani, Priya S ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Enzyme replacement therapy; Fecal incontinence; Lower urinary tract symptom; Urinary incontinence; Urinary symptom

Indexed keywords

EID: 85014843313     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2014_381     Document Type: Chapter

References (23)

1. Anger JT, Saigal CS, Stothers L, Thom DH, Rodriguez LV, Litwin MS, Urologic P, Diseases of America (2006) The prevalence of urinary incontinence among community dwelling men: results from the national health and nutrition examination survey. J Urol 176(5):2103–2108, discussion 2108
2. Basra R, Kelleher C (2007) Disease burden of overactive bladder: quality-of-life data assessed using ICI-recommended instruments. Pharmacoeconomics 25(2):129–142
3. Bijvoet AG, van de Kamp EH, Kroos MA, Ding JH, Yang BZ, Visser P, Bakker CE, Verbeet MP, Oostra BA, Reuser AJ, van der Ploeg AT (1998) Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease. Hum Mol Genet 7(1):53–62
4. Cameron AP, Heidelbaugh JJ, Jimbo M (2013) Diagnosis and office-based treatment of urinary incontinence in adults. Part one: diagnosis and testing. Ther Adv Urol 5(4):181–187
5. Fidzianska A, Lugowska A, Tylki-Szymanska A (2011) Late form of Pompe disease with glycogen storage in peripheral nerves axons. J Neurol Sci 301(1–2):59–62
6. Hagemans ML, Janssens AC, Winkel LP, Sieradzan KA, Reuser AJ, Van Doorn PA, Van der Ploeg AT (2004) Late-onset Pompe disease primarily affects quality of life in physical health domains. Neurology 63(9):1688–1692
7. Hagemans ML, Winkel LP, Hop WC, Reuser AJ, Van Doorn PA, Van der Ploeg AT (2005) Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology 64 (12):2139–2141
8. Halland M, Koloski NA, Jones M, Byles J, Chiarelli P, Forder P, Talley NJ (2013) Prevalence correlates and impact of fecal incontinence among older women. Dis Colon Rectum 56 (9):1080–1086
9. Hobson-Webb LD, Proia AD, Thurberg BL, Banugaria S, Prater SN, Kishnani PS (2012) Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature. Mol Genet Metab 106(4):462–469
10. Howard F, Steggall M (2010) Urinary incontinence in women: quality of life and help-seeking. Br J Nurs 19(12):742, 744, 746, 748–749
11. Kobayashi H, Shimada Y, Ikegami M, Kawai T, Sakurai K, Urashima T, Ijima M, Fujiwara M, Kaneshiro E, Ohashi T, Eto Y, Ishigaki K, Osawa M, Kyosen SO, Ida H (2010) Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case. Mol Genet Metab 100(1):14–19
12. Laboratories A. T. S. C. o. P. S. f. C. P. F (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117
13. Martiniuk F, Chen A, Mack A, Arvanitopoulos E, Chen Y, Rom WN, Codd WJ, Hanna B, Alcabes P, Raben N, Plotz P (1998) Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet 79(1):69–72
14. Maserejian NN, Chen S, Chiu GR, Araujo AN, Kupelian V, Hall SA, McKinlay JB (2013a) Treatment status and progression or regression of lower urinary tract symptoms among adults in a general population sample. J Urol 191(1):107–113
15. Maserejian NN, Chen S, Chiu GR, Wager CG, Kupelian V, Araujo AB, McKinlay JB (2013b) Incidence of lower urinary tract symptoms in a population-based study of men and women. Urology 82(3):560–564
16. Matthews CA, Whitehead WE, Townsend MK, Grodstein F (2013) Risk factors for urinary, fecal, or dual incontinence in the nurses’ health study. Obstet Gynecol 122(3):539–545
17. Minassian VA, Drutz HP, Al-Badr A (2003) Urinary incontinence as a worldwide problem. Int J Gynaecol Obstet 82(3):327–338
18. Naughton MJ, Donovan J, Badia X, Corcos J, Gotoh M, Kelleher C, Lukacs B, Shaw C (2004) Symptom severity and QOL scales for urinary incontinence. Gastroenterology 126(1 Suppl 1): S114–S123
19. Personius KE, Pandya S, King WM, Tawil R, McDermott MP (1994) Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group. Phys Ther 74(3):253–263
20. Remiche G, Herbaut AG, Ronchi D, Lamperti C, Magri F, Moggio M, Bresolin N, Comi GP (2012) Incontinence in late-onset Pompe disease: an underdiagnosed treatable condition. Eur Neurol 68 (2):75–78
21. van der Walt JD, Swash M, Leake J, Cox EL (1987) The pattern of involvement of adult-onset acid maltase deficiency at autopsy. Muscle Nerve 10(3):272–281
22. Wallner LP, Porten S, Meenan RT, O’Keefe Rosetti MC, Calhoun EA, Sarma AV, Clemens JQ (2009) Prevalence and severity of undiagnosed urinary incontinence in women. Am J Med 122 (11):1037–1042
23. Wokke JH, Escolar DM, Pestronk A, Jaffe KM, Carter GT, van den Berg LH, Florence JM, Mayhew J, Skrinar A, Corzo D, Laforet P (2008) Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle Nerve 38(4):1236–1245